Logo
Menu
  • Who We Are
  • How We Invest
  • Our Portfolio
    • Abzena
    • Ixlayer
    • Kiniciti
    • PathAI
  • Blog
  • Careers
  • Contact
Biospring Partners Welcomes Industry Executives To Its Advisory Board

Biospring Partners Welcomes Industry Executives To Its Advisory Board

by Biospring | Nov 9, 2022 | Advisory Board, Biospring Partners

Biospring is pleased to announce the addition of two industry executives to its Advisory Board – Arnaub Chatterjee, SVP Product and Ecosystem at Medidata and Qi Wang, CIO Portfolio Implementation and Portfolio Manager at PIMCO. Biospring’s Advisors support the...
Biomanufacturing: A Growing Field

Biomanufacturing: A Growing Field

by Biospring | Aug 1, 2022 | Advanced Therapy, Biologics, Biomanufacturing, CDMO, Cell and Gene Therapy, CGT, Drug Development, Life Sciences Technology

For a biotech company, discovering a new therapeutic candidate is a years-long, herculean achievement. A crucial question post-discovery is, can the drug be manufactured at scale? Companies must ensure that they can procure enough of a new therapy for clinical trials...
Interview with Zach Weinberg

Interview with Zach Weinberg

by Biospring | May 30, 2022 | Curie Bio, EHR, Flatiron Health, Pharma, RWD, RWE, Zach Weinberg

Zach Weinberg is a Co-Founder of Curie Bio and Operator Partners. Zach was previously Co-Founder, President, and COO of both Flatiron Health (acquired by Roche in 2018 for $2B) and Invite Media (acquired by Google in 2010 for $81M). Zach is one of the most successful...
Driving Drug Development with Data Science

Driving Drug Development with Data Science

by Biospring | Apr 26, 2022 | Data Science, Digital Health, Drug Development, Drug Discovery, Janssen, Najat Khan

We were delighted to host a discussion with Najat Khan, PhD, Chief Data Science Officer and Global Head of Strategy and Operations, Janssen Research & Development (R&D), Johnson and Johnson. As the Chief Data Science Officer, Dr. Khan leads a team of 100+ data...
Proteomics 101

Proteomics 101

by Biospring | Apr 26, 2022 | DNA, Drug Development, Drug Discovery, Life Sciences Technology, Proteins, Proteome, Proteomics

Proteomics is the study of proteins (the proteome) in a cell, tissue, or organism. This emerging sector of the life sciences is helping scientists gain a deeper understanding of molecular biology. Proteins are large, complex molecules present in all living organisms....
« Older Entries

Recent Posts

  • Biospring Partners Welcomes Industry Executives To Its Advisory Board
  • Biomanufacturing: A Growing Field
  • Interview with Zach Weinberg
  • Driving Drug Development with Data Science
  • Proteomics 101

Recent Comments

No comments to show.

Newsletter

Thank you for subscribing!

Subscribe